Table 2.
Comparison of clinical data between non-ICU group and ICU group.
| non-ICU (n = 149) | ICU (n = 27) | p value | |
|---|---|---|---|
| Sex, No (%) | 0.858a | ||
| Male | 80 (53.69%) | 15 (55.56%) | |
| Female | 69 (46.31%) | 12 (44.44%) | |
| Age (year, Mean ± SD) | 43.05 ± 18.99 | 36.30 ± 17.16 | 0.086b |
| SII (M, IQR) | 739.39 (452.01–1164.45) | 1232.84 (626.04–1697.41) | 0.011c |
| NLR (M, IQR) | 2.94 (2.08–4.35) | 5.11 (2.95–7.07) | 0.001c |
| MLR (M, IQR) | 0.28 (0.20–0.41) | 0.32 (0.23–0.65) | 0.074c |
| PLR (M, IQR) | 142.78 (111.32–191.87) | 147.66 (121.03–253.61) | 0.487c |
| mRS (M, IQR) | 2 (1–3) | 4 (3–5) | <0.001c |
| CASE (M, IQR) | 6 (4–11) | 20 (12–23) | <0.001c |
SII, Systemic immune-inflammation index; NLR, Neutrophil-to-lymphocyte ratio; MLR, Monocyte-to-lymphocyte ratio; PLR, Platelet-to-lymphocyte ratio; mRS, Modified Rankin Scale; CASE, Clinical Assessment Scale in Autoimmune Encephalitis; non-ICU, Non-intensive care unit. ICU, Intensive care unit.
a
Pearson’s chi-square test.
b
The independent samples T test.
c
Mann-Whitney U test.